e & a health policy consultants I OUR TEAM I
I Lisa THYRION I
Managing Director
Johan Eykens
Expertise
For more than 25 years I have been active in the health care sector, representing companies, promoting products with competent authorities, academics, health funds and healthcare professionals. Learning from, interacting with and sharing expertise with these stakeholders are the basis of the engagement process leading to access of new therapies to patients, the essence of our work. As a former member of the Belgian Medicines Reimbursement Committee and former chair at the Federal Agency of Medicines, I value the close collaboration with Health Care Authorities. As a Vice-President of the Council of Local Economy of Tervuren, I share my professional expertise with fellow citizens to create a lively and dynamic community.
Qualifications
-
Pharmacist – KU Leuven
-
Master of Science in Pharmacology – University of Bradford (UK)
-
Postgraduate in Business Administration – KU Leuven
Career summary
-
2002 – present: Managing Director of E&A Farma
-
Management positions with Merck-Serono, EG, MSD and Leo Pharma
Expertise
I became really passionate about the pricing and reimbursement environment when I was still in university. I had the opportunity to do an internship at Pfizer in market access. After working in the regulatory environment, I Joined E&A consultants in 2018.
Market access is really the last step to give the patient access to their medication. I think a really important message in our job, and moreover our goal is to make the healthcare system more accessible for every one of us.
Within this mindset, I’m really interested in the pricing and reimbursement environment. Working together as a team is one of the key elements for success in market access.
Qualifications
-
2017: Master in pharmaceutical sciences at the KULeuven
Career summary
-
2017-2018: Regulatory Affairs Officer at EG
-
2016-2017: Market Access Internship at Pfizer
Expertise
A strong interest in therapeutic innovation sparked me to study biotechnology and pursue a PhD in medical sciences. After completing my PhD, I switched to the pharmaceutical sector in look of a stronger focus on patient welfare, in which I strengthened medical teams in the fields of respiratory care and rare diseases. The close collaboration with market access during this period spiked my interest in pricing and reimbursement as a key element of delivering healthcare to the patient. I am delighted to now be part of the e&a team to contribute to dossiers that help making a difference at this crucial level.
Qualifications
-
2016: PhD in Medical Sciences at Ghent University
-
2011: Master in Biochemistry & Biotechnology at Ghent University
Career summary
-
2019: Medical Science Liaison Belux Rare Diseases at Kyowa Kirin
-
2016-2018: Medical Advisor Respiratory Care at Chiesi
“The bigger the dream, the more important the team.”
